Literature DB >> 20724544

Thalamic damage and long-term progression of disability in multiple sclerosis.

Maria Assunta Rocca1, Sarlota Mesaros, Elisabetta Pagani, Maria Pia Sormani, Giancarlo Comi, Massimo Filippi.   

Abstract

PURPOSE: To estimate the relative contributions of baseline thalamic atrophy and abnormalities shown at magnetization transfer (MT) magnetic resonance (MR) imaging, as well as their 12-month changes, in predicting accumulation of disability in a relatively large sample of patients with relapse-onset multiple sclerosis (MS) during an 8-year period.
MATERIALS AND METHODS: The study was conducted with approval of the institutional review board. Written informed consent was obtained from each participant. Conventional and MT MR imaging of the brain was performed at baseline and at 12-month follow-up in 13 healthy control subjects and 73 patients with relapse-onset MS; participants were monitored with clinical visits for 8 years. The following parameters were evaluated at baseline and at 12-month follow-up: volume of lesions with high signal intensity at T2-weighted imaging, volume of lesions with low signal intensity at T1-weighted imaging, mean lesion MT ratio, thalamic fraction, and thalamic MT ratio. A multivariate analysis was used to evaluate the predictors of long-term neurologic deterioration.
RESULTS: At 8-year follow-up, 44 patients showed worsening disability. During follow-up, reduction in thalamic fraction was more pronounced in patients with relapsing-remitting MS than in those with secondary progressive MS (P = .001); thalamic MT ratio decreased only in patients with secondary progressive MS (P = .007). In the multivariable model, baseline thalamic fraction (odds ratio = 0.62, P = .01) and mean percentage change in lesion MT ratio after 12 months (odds ratio = 0.90, P = .04) were independent predictors of worsening disability at 8 years. At baseline, thalamic fraction was correlated with lesion volumes at T2-weighted imaging (r = -0.75, P < .001) and T1-weighted imaging (r = -0.60, P < .001).
CONCLUSION: Thalamic atrophy is correlated with long-term accumulation of disability in patients with MS. White matter lesions are likely to contribute to the loss of tissue seen in the thalamus of patients with MS. © RSNA, 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20724544     DOI: 10.1148/radiol.10100326

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  55 in total

Review 1.  Current and new directions in MRI in multiple sclerosis.

Authors:  Eric C Klawiter
Journal:  Continuum (Minneap Minn)       Date:  2013-08

2.  Global and regional annual brain volume loss rates in physiological aging.

Authors:  Sven Schippling; Ann-Christin Ostwaldt; Per Suppa; Lothar Spies; Praveena Manogaran; Carola Gocke; Hans-Jürgen Huppertz; Roland Opfer
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

3.  Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Nat Rev Neurol       Date:  2013-03-12       Impact factor: 42.937

4.  Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.

Authors:  Yaou Liu; Yunyun Duan; Jing Huang; Zhuoqiong Ren; Zheng Liu; Huiqing Dong; Florian Weiler; Horst K Hahn; Fu-Dong Shi; Helmut Butzkueven; Frederik Barkhof; Kuncheng Li
Journal:  Eur Radiol       Date:  2017-06-30       Impact factor: 5.315

5.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

6.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

7.  SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.

Authors:  Riley Bove; Tanuja Chitnis; Bruce Ac Cree; Mar Tintoré; Yvonne Naegelin; Bernard Mj Uitdehaag; Ludwig Kappos; Samia J Khoury; Xavier Montalban; Stephen L Hauser; Howard L Weiner
Journal:  Mult Scler       Date:  2017-08-29       Impact factor: 6.312

Review 8.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

9.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 10.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.